Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xanthohumol for Prevention of Oxidative DNA Damage
NCT02432651Phase 1Completed
- Sponsor
- Oregon State University
- Start
- Mar 2015
- Primary completion
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of xanthohumol in oxidative stress, sponsored by Oregon State University. Primary endpoint: Markers of DNA damage at 63 days. Started Mar 2015; status: completed.
02
Drugs
xanthohumol
03
Conditions
oxidative stress
Beyond the preview
Go deeper on NCT02432651.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02432651.